Keyphrases
Cyclin-dependent Kinase Inhibitor
100%
CYC202
100%
R-roscovitine
100%
Human Keratinocytes (HaCaT)
100%
Keratinocytes
33%
Phosphorylation
22%
P38 MAP Kinase
22%
Differentiation Markers
22%
Epidermal Differentiation
22%
Cancer Cells
11%
Proliferating Cells
11%
Tumor Cells
11%
High Concentration
11%
Cell Density
11%
Clinical Practice
11%
Mitogen-activated Protein Kinase
11%
Cell Viability
11%
MAPK Inhibitors
11%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
11%
Heat Shock Protein 27 (HSP27)
11%
Small Heat Shock Protein (sHSP)
11%
Signal Transduction Pathway
11%
Dose Effect
11%
Caspase-3 Activation
11%
Pharmacological Agents
11%
Keratinocyte Proliferation
11%
Anticancer Agents
11%
P38 MAPK Pathway
11%
Epidermal Keratinocytes
11%
Involucrin
11%
Normal Cell Line
11%
MAPK Substrate
11%
Early Apoptosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin Dependent Kinase Inhibitor
100%
Roscovitine
100%
Normal Human
27%
Mitogen Activated Protein Kinase P38
18%
Neoplasm
9%
Malignant Neoplasm
9%
Anticarcinogen
9%
Phosphotransferase
9%
Phosphotransferase Inhibitor
9%
Caspase 3
9%
Cell Viability
9%
Heat Shock Protein 27
9%
Small Heat Shock Protein
9%
4 (4 Fluorophenyl) 2 (4 Nitrophenyl) 5 (4 Pyridyl)imidazole
9%
Involucrin
9%
Messenger RNA
9%